Correlation Between Stoke Therapeutics and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Stoke Therapeutics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Corvus Pharmaceuticals.
Diversification Opportunities for Stoke Therapeutics and Corvus Pharmaceuticals
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Stoke and Corvus is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Corvus Pharmaceuticals
Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Stoke Therapeutics is 1.45 times less risky than Corvus Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 404.00 in Corvus Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 125.00 from holding Corvus Pharmaceuticals or generate 30.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Stoke Therapeutics |
| Corvus Pharmaceuticals |
Stoke Therapeutics and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Corvus Pharmaceuticals
The main advantage of trading using opposite Stoke Therapeutics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| Stoke Therapeutics vs. Surrozen | Stoke Therapeutics vs. Armata Pharmaceuticals | Stoke Therapeutics vs. Pasithea Therapeutics Corp | Stoke Therapeutics vs. Aditxt Inc |
| Corvus Pharmaceuticals vs. Surrozen | Corvus Pharmaceuticals vs. Armata Pharmaceuticals | Corvus Pharmaceuticals vs. Pasithea Therapeutics Corp | Corvus Pharmaceuticals vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |